← Eichor
Condition: Acute Rejection Of Renal Transplant Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Acute Rejection Of Renal Transplant

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients
Phase N/A · 1 location(s) · Northwestern University · NCT01531257
Daratumumab for Late Antibody-Mediated Rejection
NA · 1 location(s) · University Hospital, Martin · NCT07081126
TreaT-Assay: the New Frontier for the Diagnosis of Acute Rejection in Kidney Transplantation
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06801262
Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute Rejection
Phase N/A · 1 location(s) · Loma Linda University · NCT05084768
Multi Center Observation of Sentinel Skin Graft for Detecting Acute Rejection After Renal Transplantation
Phase N/A · 3 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT05600634
Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
Phase N/A · 1 location(s) · Northwestern University · NCT01644903
Platelet Aggregation in the Diagnosis of Acute Graft Rejection
Phase N/A · 1 location(s) · University Hospital, Martin · NCT07275541
A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to
Phase 3 · 38 location(s) · Bristol-Myers Squibb · NCT04877288
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.